Abstracts Archive - Page 195 of 1683 - ATC Abstracts

2021 American Transplant Congress
Liver and Kidney Transplantation During the Covid-19 Pandemic Period: A Single Center Experience
M. Haberal¹, E. Karakaya¹, A. Akdur¹, E. Ayvazoglu Soy¹, F. Ozcay², E. Baskin³, S. Boyacioglu⁴, A. Torgay⁵, S. Yildirim¹, G. Moray¹, F. Yarbug Karakayali¹
¹Division of Transplantation, Department of General Surgery, Baskent University, Ankara, Turkey, ²Department of Pediatric Gastroenterology, Baskent University, Ankara, Turkey, ³Department of Pediatric Nephrology, Baskent University, Ankara, Turkey, ⁴Department of Gastroenterology, Baskent University, Ankara, Turkey, ⁵Department of Anaesthesiology, Baskent University, Ankara, Turkey
*Purpose: Introduction: Beginning of this year, when the Covid-19 pandemic has first started, it had the immediate effect of severely reducing living and deceased organ…
2021 American Transplant Congress
Covid-19 in Renal Transplant Recipients: Experience of Lithuania
M. Miglinas, M. M. Janušaitė, E. Ašakienė, L. Vareikienė
Nephrology, Vilnius University Santaros clinics, Vilnius, Lithuania
*Purpose: Renal transplant recipients are at increased susceptibility to many viral infections, including coronavirus disease 2019 (COVID-19). The purpose of this review is to define…
2021 American Transplant Congress
Covid-19 Infections Post-liver and Kidney Transplantation in a Southern Ca Program
M. E. de Vera¹, J. Woloszyn², S. Regmi², R. Rattanavich², M. Rakoski², M. Lin², P. Mehta², A. Kore², J. Weissman², C. Martens², T. Phan², B. Jerez-Aguilar², M. Robinson², E. Wells², R. Villicana², M. Nguyen²
¹Loma Linda University Health, San Bernardino, CA, ²Transplant Institute, Loma Linda University Health, San Bernardino, CA
*Purpose: Southern CA is at the epicenter of the Covid-19 pandemic. We reviewed outcomes of our center's liver, kidney, and pancreas transplant patients stricken with…
2021 American Transplant Congress
Early Review of Liver Acuity Circles Allocation
S. Noreen¹, J. Heimbach², J. Pomposelli³, M. Cafarella¹, J. Trotter⁴
¹UNOS, Richmond, VA, ²Mayo Clinic, Rochester, MN, ³UCHealth, Aurora, CO, ⁴BSWHealth, Dallas, TX
*Purpose: Acuity circles (AC) allocation was implemented on February 4, 2020, followed shortly by the declaration of national emergency for COVID-19. The goal of this…
2021 American Transplant Congress
Influence of Vitamin D Status on the Prognosis of Covid 19 in Patients with Kidney Transplant
J. Ugalde-Altamirano, I. Revuelta, A. Carrillo, M. Xipell, F. Cofan, N. Esforzado, E. Montagud, G. Piñeiro, A. Molina, P. Ventura, D. Cucchiari, F. Oppenheimer, F. Diekmann, J. Campistol, B. Bayes, J. Torregrosa
Nephrology, Hospital Clinic de Barcelona, Barcelona, Spain
*Purpose: The protective role of Vitamin D as an immunomodulator has been demonstrated in different pathologies included the viral etiology. This effect has been described…
2021 American Transplant Congress
Covid-19 Severity within One Year of Liver, Pancreas and Kidney Transplantation
H. Sarumi, J. Fisher, B. Johnson, T. Pruett
Solid Organ Transplant Surgery, University of Minnesota, Minneapolis, MN
*Purpose: The current pandemic has created uncertainty in the severity of COVID-19 in transplant recipients, especially those given lymphocyte depleting therapy within a year prior…
2021 American Transplant Congress
Donor-specific Anti-HLA Alloantibody in Kidney Transplant Recipients with COVID-19 Exhibit a Different Immunoglobulin Class and Subclass Profile When Compared to Anti-SARS-CoV-2 Antibodies
A. Girnita¹, L. Wang¹, M. Fernandez-Vina¹, E. Woodle², P. Ahearn¹, T. Yalamarti¹, M. Menon³, Y. Azzi⁴, M. Melcher¹, R. Bray⁵, H. Gebel⁵, E. Akalin⁴, P. Cravedi³, J. S. Maltzman¹
¹Stanford University, Palo Alto, CA, ²University of Cincinnati, Cincinnati, OH, ³Icahn School of Medicine, NYC, NY, ⁴Einstein School of Medicine, NYC, NY, ⁵Emory University, Atlanta, GA
*Purpose: Both anti-HLA and anti-SARS-CoV-2 antibodies target protein antigens. The aim of the present study was to compare the class and subclass profile of such…
2021 American Transplant Congress
Bamlanivimab for Covid-19 in Kidney Transplant Patients
M. Y. Jan, S. El-Sayegh, M. S. Yaqub, D. P. Mishler, O. Adebiyi, M. D. Anderson, T. E. Taber, A. Sharfuddin
Nephrology, Indiana University School of Medicine, Indianapolis, IN
*Purpose: Treatment options for patients with COVID 19 have limited efficacy in reducing severity and duration of viral symptoms as well as progression to severe…
2021 American Transplant Congress
Impact of Covid-19 Infection on Tacrolimus Levels in Solid Organ Transplant Recipients
K. Heagler, K. Tejani, S. Sanchez
Loyola University Medical Center, Maywood, IL
*Purpose: Immunocompromised patients are considered to be at high-risk for infection with SARS-CoV-2 (COVID-19). There have been observations within the transplant community that patients infected…
2021 American Transplant Congress
Feasibility of a Virtual Renal Transplant Simulation Model for Surgical Trainees in the Covid Era
O. Eletta¹, S. Iacono¹, D. Walls¹, S. Puri², B. Perry¹, C. Anderson¹, M. J. Nguyen³, A. Bongu²
¹General Surgery, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, ²Transplant, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, ³Transplant Institute, Loma Linda University Medical Center, Loma Linda, CA
*Purpose: The COVID-19 pandemic and social distancing requirements has affected our resident education curriculum. We developed a virtual renal transplant simulation session to simulate renal…